Tools
Stock profile

Avantor, Inc. (AVTR)

AVTR · Latest close $15.37 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$15.37
As of Nov 18, 2026
Tracked funds holding
5 of 149
2026 Q2 13F filings
Opened / added
0 / 5
vs previous quarter
Trimmed / exited
1
vs previous quarter

Avantor, Inc. (AVTR) is held by 5 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 5 funds adding and 1 fund trimming or exiting versus the previous quarter. Latest close $15.37 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Greenhaven Associates · Southeastern Asset Management · First Pacific Advisors — 5 tracked funds hold AVTR. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

BAXTER INTERNATIONAL INC (BAX) · PayPal Holdings, Inc. (PYPL) · Aon plc (AON) · WELLS FARGO & COMPANY/MN (WFC) · COMCAST CORP (CMCSA) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Greenhaven Associates2.82%24,637,310ADDED (+9.0%) Q3 filed Oct 26
Southeastern Asset Management2.44%4,725,478ADDED (+34.2%) Q3 filed Nov 16
First Pacific Advisors1.00%8,190,740ADDED (+1.3%) Q3 filed Nov 12
Dodge & Cox Funds0.62%120,020,974ADDED (+0.3%) Q3 filed Nov 13
Yacktman Asset Management0.58%4,770,000ADDED (+0.5%) Q3 filed Nov 2
Maverick Capital——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +51.6% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

22.666.802024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding457 of 8,857 filers
Long-only filers among them455
Change vs 2026 Q1+36 net · 440 entered · 404 exited
Shares reported, all filers698,433,499
Reported value, all filers$6.8B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryLaboratory Analytical Instruments (SIC 3826)
Revenue · FY2025$6.6B
Net income · FY2025$-530.2M
Total assets · FY2025$11.8B
Shares outstanding677,615,769
Market cap (at latest close)$10.4B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 23, 2026.

Short interest

Shares short · Oct 15, 202634,645,265
Share of shares outstanding5.11%
Days to cover4.58

Shares short at recent settlements — Jul 31, 2026: 53.2M · Aug 14, 2026: 52.2M · Aug 31, 2026: 50.2M · Sep 15, 2026: 51.4M · Sep 30, 2026: 39.3M · Oct 15, 2026: 34.6M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 23, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 16K · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 23, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Nov 6, 2025Todd Edwardsofficer29,131$732.9KNov 6, 2025SEC filing
Aug 5, 2025Eck Steven WOfficer3,476$39.6KAug 5, 2025SEC filing
Feb 27, 2025Bramwell JamesOfficer774$13.2KFeb 27, 2025SEC filing
Feb 27, 2025Eck Steven WOfficer1,033$17.6KFeb 27, 2025SEC filing
Feb 26, 2025Bramwell JamesOfficer3,758$65.9KFeb 26, 2025SEC filing
Feb 26, 2025Eck Steven WOfficer4,907$86.0KFeb 26, 2025SEC filing
Sep 5, 2024Eck Steven WOfficer3,525$88.3KSep 5, 2024SEC filing
Aug 26, 2024Wondrasch MichaelOfficer17,000$434.2KAug 26, 2024SEC filing
Jul 31, 2024Couturier ChristopheOfficer100$2.8KJul 31, 2024SEC filing
Jul 30, 2024Couturier ChristopheOfficer10,000$270.1KJul 30, 2024SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Apr 29, 2026Vanguard Capital ManagementSC 13G35,802,2635.3%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Nov 14, 2025T. Rowe Price Investment Management, Inc.SC 13G/A32,928,4154.8%Sep 30, 2025SEC filing
Oct 17, 2025BlackRock, Inc.SC 13G/A59,049,5758.7%Sep 30, 2025SEC filing
Aug 14, 2025T. Rowe Price Investment Management, Inc.SC 13G/A56,500,7158.3%Jun 30, 2025SEC filing
Aug 13, 2025Dodge & CoxSC 13G/A117,433,48417.2%Jun 30, 2025SEC filing
Feb 14, 2025T. Rowe Price Investment Management, Inc.SC 13G/A41,360,3936.1%Dec 31, 2024SEC filing
Feb 13, 2025Dodge & CoxSC 13G/A99,145,77014.6%Dec 31, 2024SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Laboratory Analytical Instruments (SIC 3826). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: no Lobbying Disclosure Act filings matched for this ticker (1999–2026).

Federal contracts: $24.7M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$2.4M
FY2022$11.2M
FY2023$10.8M
FY2024$245.2K
FY2025$0
FY2026$-1.3K

Largest awards collected

Award IDAgencyAmountStart
75N98022F00053Department of Health and Human Services$53.8KDec 22, 2021
36C24118F1634Department of Veterans Affairs$15.4KSep 14, 2018
HHSN27200014Department of Health and Human Services$10.0KAug 25, 2017
SPE2D622F37V7Department of Defense$5.8KDec 9, 2021
SPE2D622F38S4Department of Defense$5.7KDec 9, 2021

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 4 of the last 20 quarterly lists; latest 2026 Q1, ranked #23 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together250.0%+4.2%+8.4%-4.3%
Share count tripled (3x)250.0%-6.5%+4.3%-10.7%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold AVTR — ranked by lift, the co-holding pattern described in Methodology: BAXTER INTERNATIONAL INC (BAX) · PayPal Holdings, Inc. (PYPL) · Aon plc (AON) · WELLS FARGO & COMPANY/MN (WFC) · COMCAST CORP (CMCSA) · SCHWAB CHARLES CORP (SCHW).

Recent 8-K filings

FiledItemsSource
Nov 3, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 9.01 Financial Statements and ExhibitsSEC filing
Oct 28, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Sep 21, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

BAXTER INTERNATIONAL INC (BAX) · Track Record: how the signals scored · Practice timing on AVTR

One email a week: the week’s new filings and research. Subscribe free

← AVT  ·  AVTX →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.